Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Boehringer Ingelheim
Harvard Business School
Colorcon
Baxter

Last Updated: January 18, 2020

DrugPatentWatch Database Preview

Trastuzumab - Biologic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Recent Clinical Trials for trastuzumab

Identify potential brand extensions & biosimilar entrants

SponsorPhase
xuexin hePhase 2
AC Camargo Cancer CenterPhase 2
Jin-Hee AhnPhase 2

See all trastuzumab clinical trials

Recent Litigation for trastuzumab

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
CELGENE CORPORATION v. DR. REDDY'S LABORATORIES, LTD.2019-07-12
Genentech, Inc. v. Pfizer Inc.2019-04-05
Genentech, Inc. v. Immunex Rhode Island Corp.2019-03-29

See all trastuzumab litigation

PTAB Litigation
PetitionerDate
Forty Seven, Inc.2018-01-08
Pfizer, Inc.2017-06-30
Celltrion, Inc.2017-02-21

See all trastuzumab litigation

Pharmacology for trastuzumab
Mechanism of ActionHER2/Neu/cerbB2 Antagonists

Patent Text Search: US Patents for trastuzumab

These patents were identified by searching patent claims

Supplementary Protection Certificates for trastuzumab

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0753 Netherlands   Start Trial PRODUCT NAME: TRASTUZUMAB EN RECOMBINANT HUMAAN HYALURONIDASE; REGISTRATION NO/DATE: EU/1/00/145/002 20130826
0130035 00163 Estonia   Start Trial PRODUCT NAME: TRASTUZUMABEMTANSIIN;REG NO/DATE: K(2013)8149 (LOPLIK) 19.11.2013
2016 00056 Denmark   Start Trial PRODUCT NAME: IBRUTINIB, ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/14/945 C(2016)3293 20160530
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Johnson and Johnson
Baxter
Medtronic
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.